The present and future of PI3K inhibitors for cancer therapy
Pau Castel, Eneda Toska, Jeffrey A. Engelman, Maurizio Scaltriti
Topics & Concepts
PI3K/AKT/mTOR pathwayCancer therapyMedicineCancerBioinformaticsCancer researchPharmacologySignal transductionBiologyInternal medicineBiochemistryPI3K/AKT/mTOR signaling in cancerChronic Lymphocytic Leukemia ResearchProtein Degradation and Inhibitors